Work

Correction: Identification of a Novel, EBV-based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Year: 2020

Type: erratum

Abstract: In the original version of [this article][1] ([1][2]), the left panel of Fig. 2 was incorrectly labeled: the BFRF1 IgG antibody was incorrectly labeled as the BALF2 IgG antibody, and the corresponding sentence in the text was also incorrect. These errors have been corrected in the latest online HTML

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-20-1828

Authors: Anna E. Coghill, Ruth M. Pfeiffer, Carla Proietti, Wan-Lun Hsu, Yin-Chu Chien, Lea Lekieffre, Lutz Krause, Andy Teng, Jocelyn Pablo, Kelly J. Yu, Pei-Jen Lou, Cheng-Ping Wang, Zhiwei Liu, Chien-Jen Chen, Jaap Middeldorp, Jason Mulvenna, Jeff Bethony, Allan Hildesheim, Denise L. Doolan

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3087630710

Cites: 1

Cited by:

Related to: 10